Medical Legal

Bio-Rad Labs recently agreed to pay a $14.35 million dollar penalty to resolve DOJ allegations that its subsidiaries…

In April, we wrote that Asia's biggest pharmaceutical company, Takeda, and their marketing partner, Eli Lilly, faced $9…

Novartis must continue to litigate over its speaker programs, District Court Judge Paul G. Gardephe ruled earlier this…

Pharmaceutical manufacturer co-payment coupons have come under a lot of scrutiny recently. HHS-OIG recently warned these coupons…

FDA does not have “inherent reconsideration authority” to reclassify medical devices without notice and a comment…

In August, House Ways and Means Subcommittee on Health Chairman, Kevin Brady (R-TX), released the Protecting Integrity in…

An interesting False Claims Act issue cropped up in a recent $8 million settlement involving U.K.-based medical device…

Pharmaceutical manufacturers routinely offer copayment coupons to reduce or eliminate the cost of patients'…

A New York federal judge recently dismissed two separate cases brought by Fox Rx Inc.--one against Omnicare, the other…

A whistleblower’s False Claims Act (FCA) suit in the Eastern District of California has caught the attention of the…